These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1395837)

  • 21. [Respective importance of vertical and horizontal transmission of hepatitis B in the Australian archipelago (French Polynesia). Preliminary results of the vaccination of newborns].
    Boutin JP; Spiegel A; Flye Sainte-Marie F; Cartel JL; Girard M; Saliou P; Roux J
    Bull Soc Pathol Exot; 1991; 84(5 Pt 5):906-11. PubMed ID: 1840244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An efficacy trial of a mammalian cell-derived recombinant DNA hepatitis B vaccine in infants born to mothers positive for HBsAg, in Shanghai, China.
    Halliday ML; Kang LY; Rankin JG; Coates RA; Corey PN; Hu ZH; Zhou TK; Yuan GJ; Yao FL
    Int J Epidemiol; 1992 Jun; 21(3):564-73. PubMed ID: 1386063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The prevalence of the HBsAg carrier state among pregnant women and its effect on newborn infants. IV. Our experience in using hepatitis B vaccine and hepatitis B immunoglobulin to immunize infants born to mothers who carry HBsAg].
    Iliev B; Stambolov B; Marinova E; Khitkova Kh; Khristov M
    Akush Ginekol (Sofiia); 1989; 28(6):37-42. PubMed ID: 2633642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy.
    Samandari T; Fiore AE; Negus S; Williams JL; Kuhnert W; McMahon BJ; Bell BP
    Pediatrics; 2007 Aug; 120(2):e373-81. PubMed ID: 17636112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years.
    Hammitt LL; Hennessy TW; Fiore AE; Zanis C; Hummel KB; Dunaway E; Bulkow L; McMahon BJ
    Vaccine; 2007 Sep; 25(39-40):6958-64. PubMed ID: 17714836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A pilot study on universal immunization of newborn infants in an area of hepatitis B virus and primary hepatocellular carcinoma prevalence with a low dose of hepatitis B vaccine.
    Sun TT; Chu YR; Ni ZQ; Lu JH; Huang F; Ni ZP; Pei XF; Yu ZI; Liu GT
    J Cell Physiol Suppl; 1986; 4():83-90. PubMed ID: 3018008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination.
    Lu CY; Chiang BL; Chi WK; Chang MH; Ni YH; Hsu HM; Twu SJ; Su IJ; Huang LM; Lee CY
    Hepatology; 2004 Dec; 40(6):1415-20. PubMed ID: 15565627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of hepatitis B vaccination in babies born to hepatitis B surface antigen-positive mothers in Italy.
    Mele A; Tancredi F; Romanò L; Giuseppone A; Colucci M; Sangiuolo A; Lecce R; Adamo B; Tosti ME; Taliani G; Zanetti AR
    J Infect Dis; 2001 Oct; 184(7):905-8. PubMed ID: 11509998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Persistence of HB vaccine immune protection and response to hepatitis B booster immunization].
    Li H; Li R; Liao S; Yang J; Zeng X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Feb; 20(1):54-9. PubMed ID: 11367735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Interruption of perinatal transmission of HBV by Chinese recombinant hepatitis B vaccine].
    Yang C; Chen D; Li S
    Zhonghua Liu Xing Bing Xue Za Zhi; 1994 Dec; 15(6):343-5. PubMed ID: 7874702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Passive immunoprophylaxis of hepatitis B virus infections in newborn infants.
    Farmer K; Gunn T; Woodfield DG
    N Z Med J; 1985 Oct; 98(788):851-3. PubMed ID: 3864038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term response to hepatitis B vaccination and response to booster in children born to mothers with hepatitis B e antigen.
    Huang LM; Chiang BL; Lee CY; Lee PI; Chi WK; Chang MH
    Hepatology; 1999 Mar; 29(3):954-9. PubMed ID: 10051503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunogenicity and harmlessness in the newborn of a vaccine (GenHevac B) containing the antigens S and pre-S2].
    Tron F; Soulié JC; Goudeau A; Devillier P; Saliou P
    Bull Soc Pathol Exot; 1991; 84(5 Pt 5):901-5. PubMed ID: 1840243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoprophylaxis of infection with hepatitis B virus in infants born to hepatitis B surface antigen-positive carrier mothers.
    Lo KJ; Tsai YT; Lee SD; Wu TC; Wang JY; Chen GH; Yeh CL; Chiang BN; Yeh SH; Goudeau A
    J Infect Dis; 1985 Oct; 152(4):817-22. PubMed ID: 2931490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term immunogenicity and efficacy of hepatitis B vaccine in infants born to HBeAg-positive HBsAg-carrier mothers.
    Lo KJ; Lee SD; Tsai YT; Wu TC; Chan CY; Chen GH; Yeh CL
    Hepatology; 1988; 8(6):1647-50. PubMed ID: 3192179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Double-blind randomised placebo-controlled study.
    Wong VC; Ip HM; Reesink HW; Lelie PN; Reerink-Brongers EE; Yeung CY; Ma HK
    Lancet; 1984 Apr; 1(8383):921-6. PubMed ID: 6143868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A combination of hepatitis B vaccine and immunoglobulin does not protect all infants born to hepatitis B e antigen positive mothers.
    Farmer K; Gunn T; Woodfield DG
    N Z Med J; 1987 Jul; 100(827):412-4. PubMed ID: 2967932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunogenicity and safety in newborns of a new recombinant hepatitis B vaccine containing the S and pre-S2 antigens.
    Soulié JC; Devillier P; Santarelli J; Goudeau A; Vermeulen P; Guellier M; Saliou P; Hillion AM; Tron F; Huchet J
    Vaccine; 1991 Aug; 9(8):545-8. PubMed ID: 1837646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of a recombinant DNA hepatitis B vaccine alone or in combination with hepatitis B immune globulin for the prevention of perinatal acquisition of hepatitis B carriage.
    Poovorawan Y; Sanpavat S; Pongpunlert W; Chumdermpadetsuk S; Sentrakul P; Chitinand S; Sakulramrung R; Tannirundorn Y
    Vaccine; 1990 Mar; 8 Suppl():S56-9; discussion S60-2. PubMed ID: 2139286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The long-term efficacy of plasma-derived hepatitis B vaccine in babies born to carrier mothers.
    Young BW; Lee SS; Lim WL; Yeoh EK
    J Viral Hepat; 2003 Jan; 10(1):23-30. PubMed ID: 12558908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.